SHC Sotera Health Co Insider Trading

Director Pincus & Co. Warburg sells entire 19,102,952 share stake in SHC for $289.8M at $15.17; stock down 4.7% in 30 days, -23.1% from 52-week high.

Pincus & Co. Warburg liquidated his complete position in Sotera Health—19,102,952 shares for $289,753,575.94 total value—on 2026-05-13, leaving zero post-transaction holdings. The sale occurred at $15.17 while the stock has since declined to $15.27 (current price is -23.1% from its 52-week high of $19.85) and has fallen 4.7% in the 30 days since the transaction. Across his prior five trades specifically at SHC, Pincus achieved well-timed exits on 2 of 5 occasions (measured by negative 90-day returns post-sale). The complete exit warrants investor attention given the large absolute dollar value and the concentration risk this insider was previously carrying.

Warburg Pincus & Co. exits SHC entirely, selling 19,102,952 shares at $15.17 for $289,753,575.94, reducing stake to 0.

Warburg Pincus & Co. (Director) sold its entire position of 19,102,952 shares of Sotera Health Co (SHC) at $15.17 on 2026-05-13 for total proceeds of $289,753,575.94, leaving 0 shares post-transaction — a complete exit from the company. This sale occurred with SHC trading -23.1% below its 52-week high of $19.85, and the stock has declined -4.7% over the prior 30 days and -10.8% over the prior 90 days. Across Warburg Pincus & Co.'s cross-ticker sell history, the 90-day well-timed rate stands at 50.00%, and prior sells at SHC specifically showed mixed outcomes: the March 2026 sells produced a 30-day return of -2.0% and a 90-day return of +1.4%, while the December 2025 sells showed a 30-day return of +8.3% and a 90-day return of -3.9%. The complete liquidation of a 19.10M share position by a Director-level holder is a material ownership event regardless of prior timing patterns, and investors should note that SHC trades at a P/E of 37.24 against a market cap of $4.4B with quarterly net income of $26,589,000.

GTCR Investment XI LLC sold 12,735,301 shares of SHC at $15.17, exiting position entirely for $193,169,045.57

GTCR Investment XI LLC completely exited its 12,735,301-share position in Sotera Health (SHC) on 2026-05-13, selling at $15.17 per share for total proceeds of $193,169,045.57. This represents a full liquidation of the director's holdings, distinct from partial reductions. The company trades at a P/E of 37.24 with net income of $26,589,000.00 on revenue of $280,045,000.00 (annual growth +5.7%), suggesting valuation elevation relative to earnings. SHC has declined 23.1% from its 52-week high and 4.7% over the last 30 days; the broader market context shows this sale occurred amid downward price momentum. At the same-ticker level, GTCR's prior 5 trades at SHC showed mixed timing: only 2 of 5 prior sales were well-timed at the 90-day mark, indicating inconsistent execution at this security. The full exit signal warrants investor attention given its scale and the current valuation and price-action environment.